Showing results (431-440 of 447) with videos related to

Sort By:
Pageof 45
Epidemiology and Infection|January 16, 2018
Clinical characteristics of non-tuberculous mycobacterial pulmonary infections in Bamako, MaliB Kone, Y S Sarro, M Maiga, et al.
The Journal of Allergy and Clinical Immunology|January 17, 2017
Epicutaneous immunotherapy for the treatment of peanut allergy in children and young adultsStacie M Jones, Scott H Sicherer, A Wesley Burks, et al.
BMC Infectious Diseases|November 30, 2016
Tuberculosis drug resistance in Bamako, Mali, from 2006 to 2014B Diarra, D Goita, S Tounkara, et al.
Molecular Cell|October 14, 2014
Mechanism of polyubiquitination by human anaphase-promoting complex: RING repurposing for ubiquitin chain assemblyNicholas G Brown, Edmond R Watson, Florian Weissmann, et al.
Biorxiv : the Preprint Server for Biology|December 15, 2025
Ultrafast CTCF dynamics control cohesin barrier functionSergei Rudnizky, Peter J Murray, Emily W Sørensen, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 23, 2017
Performance of microscopic observation drug susceptibility for the rapid diagnosis of tuberculosis and detection of drug resistance in Bamako, MaliM Sanogo, B Kone, B Diarra, et al.
Nucleic Acids Research|June 22, 2026
A modular framework for automated segmentation and analysis of AFM imaging of chromatin organizationEmily Winther Sørensen, Sushil Pangeni, Raquel Merino Urteaga, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 11, 2020
Fluorescein diacetate and rapid molecular testing for the early identification of rifampicin resistance in MaliB Diarra, T Decroo, A Somboro, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|December 3, 2019
Diabetes Mellitus among new tuberculosis patients in Bamako, MaliB Diarra, M Tolofoudie, Y S Sarro, et al.
Lancet (London, England)|April 20, 2004
Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN StudyF van Leth, P Phanuphak, K Ruxrungtham, et al.
Pageof 45